Merck Chalks Up 2nd Fosamax Trial Win In NJ

Law360, New York (April 18, 2012, 5:02 PM EDT) -- Merck & Co. Inc. said Wednesday that a New Jersey state court jury found in its favor in a woman's suit claiming the company's osteoporosis drug Fosamax caused her jaw to deteriorate.

Jo Ann Sessner's case claiming Fosamax caused her osteonecrosis of the jaw, or jaw deterioration, was one of thousands of cases including similar allegations over the drug.

"We believe the evidence showed the company acted properly, and that Fosamax did not cause the plaintiff's dental and jaw problems," said Christy Jones of Butler Snow...
To view the full article, register now.